← SynDRA
PYROXAMIDE
SynDRA canonical compound SYN0005332 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | HDAC1 |
| Mechanism of action | HDAC inhibitor |
All known targets
Mechanisms of action (all sources)
- histone deacetylase inhibitor
- HDAC1 INHIBITOR
Cross-references
Synonyms
- Octanedioic acid hydroxyamide pyridin-3-ylamide
- POLAR HYBRID COMPOUND
- Suberoyl-3-aminopyridineamide hydroxamic acid
- N-Hydroxy-N'-3-pyridinyloctanediamide
- N'-hydroxy-N-pyridin-3-yloctanediamide
- N-hydroxy-n'-(pyridin-3-yl)octanediamide
- N-Hydroxy-N'-(3-pyridyl)-1,8-octanediamide
- N1-hydroxy-N8-(pyridin-3-yl)octanediamide
- NSC 696085
- Octanediamide, N-hydroxy-N'-3-pyridinyl-
- suberoyl-3-aminopyridineamide hydroxamic acid
- NSC696085
- 12N86DSS23
- C13H19N3O3
- UNII-12N86DSS23
- 8-(hydroxyamino)-8-oxo-N-(3-pyridyl)octanamide
- MLS006010135
- SCHEMBL154681
- CHEMBL353581
- Pyroxamide - NSC 696085
- Pyroxamide, >=97% (HPLC)
- CHEBI:93953
- DTXSID70191595
- EX-A085
- BCPP000095
- BCP02301
- ZINC3820709
- BDBM50473982
- HB1395
- MFCD13194970
- AKOS015899763
- DB12847
- N-(3-Pyridyl)-N'-hydroxyoctanediamide
- N1-hydroxy-N8-3-pyridinyloctanediamide
- N-Hydroxy-N'-3-pyridinyloctanediamid e
- N\'-hydroxy-N-pyridin-3-yloctanediamide
- NCGC00346891-01
- AC-36015
Look up PYROXAMIDE in the interactive SynDRA portal →